Combining a premade SMN protein with a Spinraza-like drug (targets SMN2 gene) helped patient-derived motor neurons; potential ...

The Phase 3 STEER trial enrolled more than 100 children with SMA type 2, ages 2-17, who were able to sit, but hadn't walked ...

The top 10 most-read stories published by SMA News Today in 2024 focused on symptoms, treatments, and diagnosis.

Columnist Helen Baldwin's youngest son's time on earth was short, but his continued impact reminds her he came into her life ...

It's been a hard year for columnist Brianna Albers, but hard times make good times better. She's decided to focus on gratitude.

Spinal muscular atrophy (SMA) is a rare genetic condition resulting in symptoms that most commonly include progressive muscle weakness and poor muscle tone. While motor function is typically most ...

As I reflect on 2024, I see that some great things have happened for me. I’m trying to figure out how to multiply those great things so they happen more often. This is one way I can gain an advantage ...

An algorithm that takes into account clinical measures of motor symptom severity alongside data on factors like age and height may help predict the risk of scoliosis in people with spinal muscular ...

Swallowing function may have improved in spinal muscular atrophy (SMA) patients since disease-modifying therapies (DMT) have become available, a review study suggests. The analysis showed problems ...

Edward Smith, MD, is an adjunct professor of pediatrics at Duke University Hospital. He earned his medical degree from the University of Mississippi School of Medicine and has practiced since 2007. He ...